BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33063676)

  • 1. Quantification of Thioguanine in DNA Using Liquid Chromatography-Tandem Mass Spectrometry for Routine Thiopurine Drug Monitoring in Patients With Pediatric Acute Lymphoblastic Leukemia.
    Choi R; Chun MR; Park J; Lee JW; Ju HY; Cho HW; Hyun JK; Koo HH; Yi ES; Lee SY
    Ann Lab Med; 2021 Mar; 41(2):145-154. PubMed ID: 33063676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes.
    Ju HY; Lee JW; Cho HW; Hyun JK; Ma Y; Yi ES; Yoo KH; Sung KW; Choi R; Koo HH; Lee SY
    PLoS One; 2021; 16(1):e0245667. PubMed ID: 33481917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography-tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standard.
    Jacobsen JH; Schmiegelow K; Nersting J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 881-882():115-8. PubMed ID: 22178190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TPMT and ITPA variants in mercaptopurine disposition.
    Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early proactive monitoring of DNA-thioguanine in patients with Crohn's disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers.
    Yang T; Chao K; Zhu X; Wang XD; Chan S; Guan YP; Mao J; Li P; Guan SX; Xie W; Gao X; Huang M
    World J Gastroenterol; 2024 Mar; 30(12):1751-1763. PubMed ID: 38617736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells.
    Pagarin S; Bolognese A; Fornasaro S; Franzin M; Hofmann U; Lucafò M; Franca R; Schwab M; Stocco G; Decorti G; Bonifacio A
    Chem Biol Interact; 2024 Jan; 387():110792. PubMed ID: 37944627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.
    Moriyama T; Nishii R; Lin TN; Kihira K; Toyoda H; Jacob N; Kato M; Koh K; Inaba H; Manabe A; Schmiegelow K; Yang JJ; Hori H
    Pharmacogenet Genomics; 2017 Jun; 27(6):236-239. PubMed ID: 28445187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.
    Lennard L; Cartwright CS; Wade R; Richards SM; Vora A
    Br J Clin Pharmacol; 2013 Jul; 76(1):125-36. PubMed ID: 23252716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.
    Lennard L; Van Loon JA; Lilleyman JS; Weinshilboum RM
    Clin Pharmacol Ther; 1987 Jan; 41(1):18-25. PubMed ID: 3467886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate polyglutamate quantification for clinical application in patients with pediatric acute lymphoblastic leukemia in association with genetic polymorphisms.
    Choi R; Chun MR; Park J; Won H; Kim S; Lee JW; Ju HY; Cho HW; Hyun JK; Koo HH; Yi ES; Lee SY
    J Pharm Biomed Anal; 2021 Jul; 201():114124. PubMed ID: 34000579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
    Dervieux T; Meyer G; Barham R; Matsutani M; Barry M; Boulieu R; Neri B; Seidman E
    Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising "MINT" sequencing strategy and therapeutic "DNA-TG" monitoring.
    Guo HL; Zhao YT; Wang WJ; Dong N; Hu YH; Zhang YY; Chen F; Zhou L; Li T
    Front Pharmacol; 2022; 13():941182. PubMed ID: 36238550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia.
    Moon SY; Lim JH; Kim EH; Nam Y; Yu KS; Hong KT; Choi JY; Hong CR; Kim H; Kang HJ; Shin HY; Lee K; Song J; Lee SY; Song SH
    Ther Drug Monit; 2019 Feb; 41(1):75-85. PubMed ID: 30507626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three methods for measuring thiopurine methyltransferase activity in red blood cells and human leukemia cells.
    Karim H; Appell ML; Fotoohi A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():80-5. PubMed ID: 24113235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
    Nielsen SN; Toksvang LN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Appell ML; Hjalgrim LL; Schmiegelow K
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):271-279. PubMed ID: 33928426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia.
    Larsen RH; Utke Rank C; Grell K; Nørgaard Møller L; Malthe Overgaard U; Kampmann P; Nersting J; Degn M; Nygaard Nielsen S; Holst H; Klug Albertsen B; Skov Wehner P; Thude Callesen M; Kanerva J; Leth Frandsen T; Als-Nielsen B; Lyngsie Hjalgrim L; Schmiegelow K
    Haematologica; 2021 Nov; 106(11):2824-2833. PubMed ID: 34047177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy.
    Warren DJ; Andersen A; Slørdal L
    Cancer Res; 1995 Apr; 55(8):1670-4. PubMed ID: 7712473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-Thioguanine Nucleotides as a Marker for Thiopurine Induced Late Leukopenia after Dose Optimizing by NUDT15 C415T in Chinese Patients with IBD.
    Zhu X; Chao K; Yang T; Wang XD; Guan S; Tang J; Xie W; Yu AM; Yang QF; Li M; Yang HS; Diao N; Hu PJ; Gao X; Huang M
    Clin Pharmacol Ther; 2022 Dec; 112(6):1236-1242. PubMed ID: 36002392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of Thiopurine Metabolites in Human Erythrocytes by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Li L; Atkinson N; Crews KR; Molinelli AR
    Methods Mol Biol; 2024; 2737():443-452. PubMed ID: 38036845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy: results from a large Swedish patient population.
    Hindorf U; Peterson C; Almer S
    Ther Drug Monit; 2004 Dec; 26(6):673-8. PubMed ID: 15570193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.